The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells

Mio Kawaguchi, Fumio Kokubu, Shau Ku Huang, Tetsuya Homma, Miho Odaka, Shin Watanabe, Shintaro Suzuki, Koushi Ieki, Satoshi Matsukura, Masatsugu Kurokawa, Mitsuru Adachi

Research output: Contribution to journalArticle

Abstract

Background: IL-17F is involved in airway inflammation, but its biologic activity and signaling pathway remain incompletely defined. Interferon-γ-inducible protein 10 (IP-10) is widely expressed and plays a role in airway inflammatory diseases. Objective: We sought to investigate the functional linkage between IL-17F and IP-10 expression in bronchial epithelial cells. Methods: Bronchial epithelial cells were cultured in the presence or absence of IL-17F, and/or a TH1 cytokine, TH2 cytokines, proinflammatory cytokines, various kinase inhibitors, or a Raf1 dominant-negative mutant to analyze the expression of IP-10. Moreover, the involvement of p90 ribosomal S6 kinase (p90RSK) and cyclic AMP response element-binding protein (CREB) in IL-17F-induced IP-10 expression were investigated. Results: IL-17F induces the gene and protein expression of IP-10. The addition of IFN-γ, IL-1β, and TNF-α augmented IL-17F-induced IP-10 expression. The mitogen-activated protein kinase kinase (MEK) inhibitors PD98059, U0126, and Raf1 kinase inhibitor I significantly inhibited its production. In contrast, a p38 inhibitor, a JNK inhibitor, protein kinase C inhibitors, and a phosphatidylinositol 3-kinase inhibitor, showed no inhibitory effect. Furthermore, overexpression of a Raf1 dominant-negative mutant inhibited its expression. Of interest, IL-17F phosphorylated p90RSK and CREB, and transfection of the cells with a short interfering RNA for p90RSK or CREB inhibited its expression, suggesting p90RSK and CREB as novel signaling molecules of IL-17F. Conclusion: IL-17F is a potent inducer of IP-10 in bronchial epithelial cells through the activation of the Raf1-MEK1/2-extracellular signal-regulated kinase 1/2-p90RSK-CREB pathway, supporting its regulatory role in airway inflammation. Clinical implications: The IL-17F-IP-10 axis might be a novel and critical therapeutic target for airway inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)1408-1414
Number of pages7
JournalThe Journal of Allergy and Clinical Immunology
Volume119
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Interleukin-17
90-kDa Ribosomal Protein S6 Kinases
Epithelial Cells
Cyclic AMP Response Element-Binding Protein
Proteins
Mitogen-Activated Protein Kinase Kinases
Phosphotransferases
Phosphatidylinositol 3-Kinase
Chemokine CXCL10
Cytokines
Inflammation
Mitogen-Activated Protein Kinase 3
Protein C Inhibitor
Mitogen-Activated Protein Kinase 1
Protein Kinase Inhibitors
Interleukin-1
Protein Kinase C
Small Interfering RNA
Transfection
Gene Expression

Keywords

  • cyclic AMP response element-binding protein
  • Extracellular signal-regulated kinase 1/2
  • IL-17F
  • interferon-γ-inducible protein 10
  • p90 ribosomal S6 kinase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells. / Kawaguchi, Mio; Kokubu, Fumio; Huang, Shau Ku; Homma, Tetsuya; Odaka, Miho; Watanabe, Shin; Suzuki, Shintaro; Ieki, Koushi; Matsukura, Satoshi; Kurokawa, Masatsugu; Adachi, Mitsuru.

In: The Journal of Allergy and Clinical Immunology, Vol. 119, No. 6, 06.2007, p. 1408-1414.

Research output: Contribution to journalArticle

Kawaguchi, M, Kokubu, F, Huang, SK, Homma, T, Odaka, M, Watanabe, S, Suzuki, S, Ieki, K, Matsukura, S, Kurokawa, M & Adachi, M 2007, 'The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells', The Journal of Allergy and Clinical Immunology, vol. 119, no. 6, pp. 1408-1414. https://doi.org/10.1016/j.jaci.2007.02.036
Kawaguchi, Mio ; Kokubu, Fumio ; Huang, Shau Ku ; Homma, Tetsuya ; Odaka, Miho ; Watanabe, Shin ; Suzuki, Shintaro ; Ieki, Koushi ; Matsukura, Satoshi ; Kurokawa, Masatsugu ; Adachi, Mitsuru. / The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells. In: The Journal of Allergy and Clinical Immunology. 2007 ; Vol. 119, No. 6. pp. 1408-1414.
@article{662fa47ca8ae4823b6f1ef493654e007,
title = "The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells",
abstract = "Background: IL-17F is involved in airway inflammation, but its biologic activity and signaling pathway remain incompletely defined. Interferon-γ-inducible protein 10 (IP-10) is widely expressed and plays a role in airway inflammatory diseases. Objective: We sought to investigate the functional linkage between IL-17F and IP-10 expression in bronchial epithelial cells. Methods: Bronchial epithelial cells were cultured in the presence or absence of IL-17F, and/or a TH1 cytokine, TH2 cytokines, proinflammatory cytokines, various kinase inhibitors, or a Raf1 dominant-negative mutant to analyze the expression of IP-10. Moreover, the involvement of p90 ribosomal S6 kinase (p90RSK) and cyclic AMP response element-binding protein (CREB) in IL-17F-induced IP-10 expression were investigated. Results: IL-17F induces the gene and protein expression of IP-10. The addition of IFN-γ, IL-1β, and TNF-α augmented IL-17F-induced IP-10 expression. The mitogen-activated protein kinase kinase (MEK) inhibitors PD98059, U0126, and Raf1 kinase inhibitor I significantly inhibited its production. In contrast, a p38 inhibitor, a JNK inhibitor, protein kinase C inhibitors, and a phosphatidylinositol 3-kinase inhibitor, showed no inhibitory effect. Furthermore, overexpression of a Raf1 dominant-negative mutant inhibited its expression. Of interest, IL-17F phosphorylated p90RSK and CREB, and transfection of the cells with a short interfering RNA for p90RSK or CREB inhibited its expression, suggesting p90RSK and CREB as novel signaling molecules of IL-17F. Conclusion: IL-17F is a potent inducer of IP-10 in bronchial epithelial cells through the activation of the Raf1-MEK1/2-extracellular signal-regulated kinase 1/2-p90RSK-CREB pathway, supporting its regulatory role in airway inflammation. Clinical implications: The IL-17F-IP-10 axis might be a novel and critical therapeutic target for airway inflammatory diseases.",
keywords = "cyclic AMP response element-binding protein, Extracellular signal-regulated kinase 1/2, IL-17F, interferon-γ-inducible protein 10, p90 ribosomal S6 kinase",
author = "Mio Kawaguchi and Fumio Kokubu and Huang, {Shau Ku} and Tetsuya Homma and Miho Odaka and Shin Watanabe and Shintaro Suzuki and Koushi Ieki and Satoshi Matsukura and Masatsugu Kurokawa and Mitsuru Adachi",
year = "2007",
month = "6",
doi = "10.1016/j.jaci.2007.02.036",
language = "English (US)",
volume = "119",
pages = "1408--1414",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - The IL-17F signaling pathway is involved in the induction of IFN-γ-inducible protein 10 in bronchial epithelial cells

AU - Kawaguchi, Mio

AU - Kokubu, Fumio

AU - Huang, Shau Ku

AU - Homma, Tetsuya

AU - Odaka, Miho

AU - Watanabe, Shin

AU - Suzuki, Shintaro

AU - Ieki, Koushi

AU - Matsukura, Satoshi

AU - Kurokawa, Masatsugu

AU - Adachi, Mitsuru

PY - 2007/6

Y1 - 2007/6

N2 - Background: IL-17F is involved in airway inflammation, but its biologic activity and signaling pathway remain incompletely defined. Interferon-γ-inducible protein 10 (IP-10) is widely expressed and plays a role in airway inflammatory diseases. Objective: We sought to investigate the functional linkage between IL-17F and IP-10 expression in bronchial epithelial cells. Methods: Bronchial epithelial cells were cultured in the presence or absence of IL-17F, and/or a TH1 cytokine, TH2 cytokines, proinflammatory cytokines, various kinase inhibitors, or a Raf1 dominant-negative mutant to analyze the expression of IP-10. Moreover, the involvement of p90 ribosomal S6 kinase (p90RSK) and cyclic AMP response element-binding protein (CREB) in IL-17F-induced IP-10 expression were investigated. Results: IL-17F induces the gene and protein expression of IP-10. The addition of IFN-γ, IL-1β, and TNF-α augmented IL-17F-induced IP-10 expression. The mitogen-activated protein kinase kinase (MEK) inhibitors PD98059, U0126, and Raf1 kinase inhibitor I significantly inhibited its production. In contrast, a p38 inhibitor, a JNK inhibitor, protein kinase C inhibitors, and a phosphatidylinositol 3-kinase inhibitor, showed no inhibitory effect. Furthermore, overexpression of a Raf1 dominant-negative mutant inhibited its expression. Of interest, IL-17F phosphorylated p90RSK and CREB, and transfection of the cells with a short interfering RNA for p90RSK or CREB inhibited its expression, suggesting p90RSK and CREB as novel signaling molecules of IL-17F. Conclusion: IL-17F is a potent inducer of IP-10 in bronchial epithelial cells through the activation of the Raf1-MEK1/2-extracellular signal-regulated kinase 1/2-p90RSK-CREB pathway, supporting its regulatory role in airway inflammation. Clinical implications: The IL-17F-IP-10 axis might be a novel and critical therapeutic target for airway inflammatory diseases.

AB - Background: IL-17F is involved in airway inflammation, but its biologic activity and signaling pathway remain incompletely defined. Interferon-γ-inducible protein 10 (IP-10) is widely expressed and plays a role in airway inflammatory diseases. Objective: We sought to investigate the functional linkage between IL-17F and IP-10 expression in bronchial epithelial cells. Methods: Bronchial epithelial cells were cultured in the presence or absence of IL-17F, and/or a TH1 cytokine, TH2 cytokines, proinflammatory cytokines, various kinase inhibitors, or a Raf1 dominant-negative mutant to analyze the expression of IP-10. Moreover, the involvement of p90 ribosomal S6 kinase (p90RSK) and cyclic AMP response element-binding protein (CREB) in IL-17F-induced IP-10 expression were investigated. Results: IL-17F induces the gene and protein expression of IP-10. The addition of IFN-γ, IL-1β, and TNF-α augmented IL-17F-induced IP-10 expression. The mitogen-activated protein kinase kinase (MEK) inhibitors PD98059, U0126, and Raf1 kinase inhibitor I significantly inhibited its production. In contrast, a p38 inhibitor, a JNK inhibitor, protein kinase C inhibitors, and a phosphatidylinositol 3-kinase inhibitor, showed no inhibitory effect. Furthermore, overexpression of a Raf1 dominant-negative mutant inhibited its expression. Of interest, IL-17F phosphorylated p90RSK and CREB, and transfection of the cells with a short interfering RNA for p90RSK or CREB inhibited its expression, suggesting p90RSK and CREB as novel signaling molecules of IL-17F. Conclusion: IL-17F is a potent inducer of IP-10 in bronchial epithelial cells through the activation of the Raf1-MEK1/2-extracellular signal-regulated kinase 1/2-p90RSK-CREB pathway, supporting its regulatory role in airway inflammation. Clinical implications: The IL-17F-IP-10 axis might be a novel and critical therapeutic target for airway inflammatory diseases.

KW - cyclic AMP response element-binding protein

KW - Extracellular signal-regulated kinase 1/2

KW - IL-17F

KW - interferon-γ-inducible protein 10

KW - p90 ribosomal S6 kinase

UR - http://www.scopus.com/inward/record.url?scp=34249777801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249777801&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2007.02.036

DO - 10.1016/j.jaci.2007.02.036

M3 - Article

VL - 119

SP - 1408

EP - 1414

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 6

ER -